NATACYN

LOE Approaching

natamycin

NDAOPHTHALMICSUSPENSIONPriority Review
Approved
Oct 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

CLINICAL PHARMACOLOGY: Natamycin is a tetraene polyene antibiotic derived from Streptomyces natalensis . It possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium and Penicillium . The mechanism of action appears to be…

Pharmacologic Class:

Polyene Antimicrobial

Indications (3)

fungal blepharitisconjunctivitiskeratitis caused by susceptible organisms including Fusarium solani keratitis
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers